Objectives To prospectively investigate the pre and intraprocedural risk factors for immediate (IF) and delayedonset (DOF) fever development after percutaneous transhepatic biliary drainage (PTBD).
Methods Institutional review board approval and
informed patient consent were obtained. Between February
2013 and February 2014, 97 afebrile patients (77 at the
Sapienza University of Rome, Italy and 20 at the Sun Yatsen University of Guangzhou, China) with benign (n = 31)
and malignant (n = 66) indications for a first PTBD were
prospectively enrolled. Thirty pre- and intra-procedural
clinical/radiological characteristics, including the amount
of contrast media injected prior to PTBD placement, were
collected in relation to the development of IF (within 24 h)
or DOF (after 24 h). Fever was defined as C37.5 C.
Binary logistic regression analysis was used to assess
independent associations with IF and DOF.
Results Fourteen (14.4 %) patients developed IF and 17
(17.5 %) developed DOF. At multivariable analysis, IF
was associated with pre-procedural absence of intrahepatic
bile duct dilatation (OR 63.359; 95 % CI 2.658–1510.055;
P = 0.010) and low INR (OR 4.7 9 10-4
; 95 % CI
0.000–0.376; P = 0.025), while DOF was associated with
unsatisfactory biliary drainage at the end of PTBD (OR
4.571; 95 % CI 1.161–17.992; P = 0.030)